Gut health food supplement changing the lives of people living with Irritable Bowel Syndrome (IBS) and other digestive illnesses and discomfort.
The Symprove brand was launched in 2010 by Barry Smith on his farm in Farnham, Surrey. Barry discovered that his innovative probiotic formula could not only help the animals on his farm live disease-free lives without antibiotics – but could also benefit human health.
Over the following decade, Symprove’s liquid supplement containing live, active multi-strain bacteria, supported by its patented delivery system allowing the bacteria to “arrive, survive and thrive” in the gut, was recognised as uniquely effective by some of the world’s leading academics.
Interest in gut health has grown exponentially in recent years, with advances in scientific research uncovering how the diversity and balance of bacteria in the microbiome affects many conditions – not only gut-related issues such as IBS and IBD, but also Parkinson’s and dementia, cardiovascular health, mood, and mental wellbeing. While the science is still emerging, it has become clear that people with many different diseases tend to have a less diverse or unbalanced microbiome.
With customer feedback regularly describing Symprove as “life-changing”, it is unsurprising that the company’s daily-use, subscription-based product – sold primarily through its direct-to-consumer website – is growing rapidly, fuelled both by increasing consumer awareness and recommendations from doctors and nutritionists.
Learn more at the official Symprove website.
Gut health food supplement changing the lives of people living with Irritable Bowel Syndrome (IBS) and other digestive illnesses and discomfort.
The Symprove brand was launched in 2010 by Barry Smith on his farm in Farnham, Surrey. Barry discovered that his innovative probiotic formula could not only help the animals on his farm live disease-free lives without antibiotics – but could also benefit human health.
Over the following decade, Symprove’s liquid supplement containing live, active multi-strain bacteria, supported by its patented delivery system allowing the bacteria to “arrive, survive and thrive” in the gut, was recognised as uniquely effective by some of the world’s leading academics.
Interest in gut health has grown exponentially in recent years, with advances in scientific research uncovering how the diversity and balance of bacteria in the microbiome affects many conditions – not only gut-related issues such as IBS and IBD, but also Parkinson’s and dementia, cardiovascular health, mood, and mental wellbeing. While the science is still emerging, it has become clear that people with many different diseases tend to have a less diverse or unbalanced microbiome.
With customer feedback regularly describing Symprove as “life-changing”, it is unsurprising that the company’s daily-use, subscription-based product – sold primarily through its direct-to-consumer website – is growing rapidly, fuelled both by increasing consumer awareness and recommendations from doctors and nutritionists.
Learn more at the official Symprove website.